These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 288106)

  • 1. Adjuvant therapy of operable primary osteosarcoma-cancer and Leukemia Group B experience.
    Cortes EP; Holland JF; Glidewell O
    Recent Results Cancer Res; 1978; 68():16-24. PubMed ID: 288106
    [No Abstract]   [Full Text] [Related]  

  • 2. Adriamycin in the adjuvant treatment of operable osteosarcoma.
    Fossati-Bellani F; Gasparini M; Bonadonna G
    Recent Results Cancer Res; 1978; 68():25-7. PubMed ID: 288107
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant treatment with adriamycin in primary operable osteosarcoma.
    Bellani FF; Gasparini M; Gennari L; Fontanillas L; Bonadonna G
    Cancer Treat Rep; 1978 Feb; 62(2):279-81. PubMed ID: 346217
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical treatment for osteosarcoma.
    Springfield DS; Schmidt R; Graham-Pole J; Marcus RB; Spanier SS; Enneking WF
    J Bone Joint Surg Am; 1988 Sep; 70(8):1124-30. PubMed ID: 3166461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amputation and adriamycin in primary osteosarcoma.
    Cortes EP; Holland JF; Wang JJ; Sinks LF; Blom J; Senn H; Bank A; Glidewell O
    N Engl J Med; 1974 Nov; 291(19):998-1000. PubMed ID: 4528415
    [No Abstract]   [Full Text] [Related]  

  • 6. Doxorubicin in disseminated osteosarcoma.
    Cores EP; Holland JF; Wang JJ; Sinks LF
    JAMA; 1972 Sep; 221(10):1132-8. PubMed ID: 4512088
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant therapy in the management of osteosarcoma: need for critical reassessment.
    Breur K; van der Schueren E
    Recent Results Cancer Res; 1978; 68():5-15. PubMed ID: 288110
    [No Abstract]   [Full Text] [Related]  

  • 8. [Goal and results of the COSS study].
    Flege S; Bielack S
    Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):282-8. PubMed ID: 15503258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenic sarcoma (osteosarcoma): results of therapy.
    Stein JJ
    Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):607-13. PubMed ID: 804824
    [No Abstract]   [Full Text] [Related]  

  • 10. Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?
    Lange B; Levine AS
    Cancer Treat Rep; 1982 Sep; 66(9):1699-704. PubMed ID: 6749284
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Osteosarcoma Working Party Group.
    Recent Results Cancer Res; 1978; 68():28-32. PubMed ID: 288108
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-radiological assessment of chemotherapy for osteosarcoma received prior to surgery].
    Krzhivitskiĭ PI; Vesnin AG; Kolygin BA; Turkevich EA; Zasul'skiĭ FIu
    Vopr Onkol; 2004; 50(4):430-4. PubMed ID: 15605766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopsy technique in the treatment of osteosarcoma.
    Cara del Rosal JA; Cañadell J
    Int Orthop; 1994; 18(6):375-8. PubMed ID: 7698871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.
    Souhami RL; Craft AW; Van der Eijken JW; Nooij M; Spooner D; Bramwell VH; Wierzbicki R; Malcolm AJ; Kirkpatrick A; Uscinska BM; Van Glabbeke M; Machin D
    Lancet; 1997 Sep; 350(9082):911-7. PubMed ID: 9314869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
    Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteosarcoma--the winds of change.
    Mills EE
    S Afr Med J; 1978 May; 53(18):695-8. PubMed ID: 308700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.
    Smeland S; Müller C; Alvegard TA; Wiklund T; Wiebe T; Björk O; Stenwig AE; Willén H; Holmström T; Follerås G; Brosjö O; Kivioja A; Jonsson K; Monge O; Saeter G
    Eur J Cancer; 2003 Mar; 39(4):488-94. PubMed ID: 12751380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.